Basophilic histamine content and release during venom immunotherapy: Insights by flow cytometry

Cytometry Part B - Clinical Cytometry

Volumn 84 B, Issue 3, 2013, Pages 173-178

  Nullens, S ^a   Sabato, V ^a   Faber, M ^a   Leysen, J ^a   Bridts, C H ^a   De Clerck, L S ^a   Falcone, F H ^b   Maurer, M ^c   Ebo, D G ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

allergen immunotherapies; basophil; flow cytometry; histamine

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); CD63 ANTIGEN; FLUOROCHROME; HISTAMINE; WASP VENOM;

ADOLESCENT; ADULT; AGED; ALLERGY; ANAPHYLAXIS; ARTICLE; BASOPHIL; CELL ACTIVATION; CELL COUNT; CHILD; CLINICAL ARTICLE; CONJUGATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MAINTENANCE THERAPY; MALE; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; VESPULA VULGARIS;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIGENS, CD63; BASOPHILS; CHILD; DESENSITIZATION, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HISTAMINE; HISTAMINE RELEASE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES; WASP VENOMS; WASPS;

EID: 84876463777     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.21084     Document Type: Article

References (26)

1. Bilo MB,. Anaphylaxis caused by Hymenoptera stings: From epidemiology to treatment. Allergy 2011; 66 Suppl 95: 35-7.
2. Sasvary T, Muller U,. Fatalities from insect stings in Switzerland 1978 to 1987. Schweiz Med Wochenschr 1994; 124: 1887-1894.
3. Krishna MT, Ewan PW, Diwakar L, Durham SR, Frew AJ, Leech SC, Nasser SM,. Diagnosis and management of hymenoptera venom allergy: British society for allergy and clinical immunology (BSACI) guidelines. Clin Exp Allergy 2011; 41: 1201-1220.
4. Bilo BM, Bonifazi F,. Hymenoptera venom immunotherapy. Immunotherapy 2011; 3: 229-246.
5. van der Zwan JC, Flinterman J, Jankowski IG, Kerckhaert JA,. Hyposensitisation to wasp venom in six hours. Br Med J (Clin Res Ed) 1983; 287: 1329-1331.
6. Ross RN, Nelson HS, Finegold I,. Effectiveness of specific immunotherapy in the treatment of hymenoptera venom hypersensitivity: A meta-analysis. Clin Ther 2000; 22: 351-358.
7. Jutel M, Akdis CA,. Immunological mechanisms of allergen-specific immunotherapy. Allergy 2011; 66: 725-732.
8. Ozdemir C, Kucuksezer UC, Akdis M, Akdis CA,. Mechanisms of immunotherapy to wasp and bee venom. Clin Exp Allergy 2011; 41: 1226-1234.
9. Bernstein DI, Mittman RJ, Kagen SL, Korbee L, Enrione M, Bernstein IL,. Clinical and immunologic studies of rapid venom immunotherapy in Hymenoptera-sensitive patients. J Allergy Clin Immunol 1989; 84: 951-959.
10. Stephan V, Kuhr J, Urbanek R,. Relevance of basophil histamine release changes during venom immunotherapy. Allergy 1989; 44: 453-459.
11. Pierkes M, Bellinghausen I, Hultsch T, Metz G, Knop J, Saloga J,. Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-gamma production of T cells. J Allergy Clin Immunol 1999; 103: 326-332.
12. Jutel M, Muller UR, Fricker M, Rihs S, Pichler WJ, Dahinden C,. Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils. Clin Exp Allergy 1996; 26: 1112-1118.
13. Bauer C, Przybilla B, Eberlein B, Kolsouzidou S, Rueff F,. Changes in intracellular cyclic adenosine monophosphate levels in peripheral blood leukocytes during immunotherapy with vespid venom. Ann Allergy Asthma Immunol 2007; 98: 281-285.
14. Eberlein-Konig B, Ullmann S, Thomas P, Przybilla B,. Tryptase and histamine release due to a sting challenge in bee venom allergic patients treated successfully or unsuccessfully with hyposensitization. Clin Exp Allergy 1995; 25: 704-712.
15. Maintz L, Bussmann C, Bieber T, Novak N,. Contribution of histamine metabolism to tachyphylaxis during the buildup phase of rush immunotherapy. J Allergy Clin Immunol 2009; 123: 701-703.
16. Plewako H, Wosinska K, Arvidsson M, Bjorkander J, Skov PS, Hakansson L, Rak S,. Basophil interleukin 4 and interleukin 13 production is suppressed during the early phase of rush immunotherapy. Int Arch Allergy Immunol 2006; 141: 346-353.
17. Novak N, Mete N, Bussmann C, Maintz L, Bieber T, Akdis M, Zumkehr J, Jutel M, Akdis C,. Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2. J Allergy Clin Immunol 2012; 130: 1153-1158.
18. Ebo DG, Bridts CH, Mertens CH, Hagendorens MM, Stevens WJ, De Clerck LS,. Analyzing histamine release by flow cytometry (HistaFlow): A novel instrument to study the degranulation patterns of basophils. J Immunol Methods 2012; 375: 30-38.
19. Stevens WJ, Ebo DG, De Clerck LS, Bridts CH, De Gendt CM, Mertens AV,. Evolution of lymphocyte transformation to wasp venom antigen during immunotherapy for wasp venom anaphylaxis. Clin Exp Allergy 1998; 28: 249-252.
20. Ebo DG, Hagendorens MM, Schuerwegh AJ, Beirens LM, Bridts CH, De Clerck LS, Stevens WJ,. Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy. Cytometry B Clin Cytom 2007; 72B: 196-203.
21. Hirata N, Takeuchi K, Ukai K, Sakakura Y,. Expression of histidine decarboxylase messenger RNA and histamine N-methyltransferase messenger RNA in nasal allergy. Clin Exp Allergy 1999; 29: 76-83.
22. Ribbing C, Engblom C, Lappalainen J, Lindstedt K, Kovanen PT, Karlsson MA, Lundeberg L, Johansson C, Nilsson G, Lunderius-Andersson C, Scheynius A,. Mast cells generated from patients with atopic eczema have enhanced levels of granule mediators and an impaired Dectin-1 expression. Allergy 2011; 66: 110-119.
23. Verweij MM, De Knop KJ, Bridts CH, De Clerck LS, Stevens WJ, Ebo DG,. P38 mitogen-activated protein kinase signal transduction in the diagnosis and follow up of immunotherapy of wasp venom allergy. Cytometry B Clin Cytom 2010; 78B: 302-307.
24. Cichocka-Jarosz E, Dorynska A, Pietrzyk JJ, Spiewak R,. Laboratory markers of mast cell and basophil activation in monitoring rush immunotherapy in bee venom-allergic children. Immunotherapy 2011; 3: 1013-1017.
25. Zitnik SE, Vesel T, Avcin T, Silar M, Kosnik M, Korosec P,. Monitoring honeybee venom immunotherapy in children with the basophil activation test. Pediatr Allergy Immunol 2012; 23: 166-172.
26. Erzen R, Kosnik M, Silar M, Korosec P,. Basophil response and the induction of a tolerance in venom immunotherapy: A long-term sting challenge study. Allergy 2012; 67: 822-830.